CorMedix Inc
NASDAQ:CRMD

  • LAST PRICE
    9.9500
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    10.0100/ 1
  • Ask / Lots
    10.4000/ 1
  • Open / Previous Close
    --- / 9.9500
  • Day Range
    ---
  • 52 Week Range
    2.8900
    13.8500
  • Volume
    318

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Nov 4, 2024

  • Oct 31, 2024

  • Oct 30, 2024

      Show headlines and story abstract

    • 11:56AM ET on Wednesday Oct 30, 2024 by Dow Jones
      Companies Mentioned: CRMD

      CorMedix Inc. ( CRMD ) is currently at $10.93, down $2.04 or 15.73%

      --Would be lowest close since Oct. 17, 2024, when it closed at $10.49

      --On pace for largest percent decrease since June 29, 2023, when it fell 22.29%

    • 7:32AM ET on Wednesday Oct 30, 2024 by MT Newswires
      Companies Mentioned: CRMD
      07:32 AM EDT, 10/30/2024 (MT Newswires) -- ...

    • 7:30AM ET on Wednesday Oct 30, 2024 by Dow Jones
      Companies Mentioned: CRMD
      Income Taxes (2,776,812) (9,744,354) (32,789,194) (31,585,198) Tax benefit - - 1,394,770 - ----------- ----------- ----------- ----------- Net Loss (2,776,812) (9,744,354) (31,394,424) (31,585,198) Other Comprehensive Income (Loss) Total other comprehensive income (loss) 3,389 (6,298) (4,988) 1,656 ----------- ----------- ----------- ----------- Other Comprehensive (Loss) Income $ (2,773,423) $ (9,750,652) $(31,399,412) $(31,583,542) =========== =========== =========== =========== Net Loss Per Common Share -- Basic and Diluted $ (0.05) $ (0.17) $ (0.54) $ (0.65) =========== =========== =========== =========== Weighted Average Common Shares Outstanding -- Basic and Diluted 58,825,221 56,553,174 57,986,190 48,715,585 =========== =========== =========== =========== CORMEDIX INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEET DATA September 30, December 31, 2024 2023 (Unaudited) (Audited) ------------- ------------- ASSETS Cash, cash equivalents and restricted cash $ 35,391,222 $ 43,823,192 Short-term investments $ 10,743,562 $ 32,388,130 Total Assets $ 77,586,194 $ 82,059,957 Total Liabilities $ 18,873,926 $ 11,917,528 Accumulated deficit $(353,094,437) $(321,700,013) Total Stockholders' Equity $ 58,712,268 $ 70,142,429 CORMEDIX INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) For the Nine Months Ended September 30, -------------------------------- 2024 2023 ------------ ------------ Cash Flows from Operating Activities: Net loss $ (31,394,424) $ (31,585,198) Net cash used in operating activities (45,000,117) (27,663,786) Cash Flows Used in Investing Activities: Net cash provided by (used in) investing activities 21,534,874 (17,659,477) Cash Flows from Financing Activities: Net cash provided by financing activities 15,033,751 55,449,154 Net (Decrease) Increase in Cash and Cash Equivalents (8,431,970) 10,126,276 Cash and Cash Equivalents and Restricted Cash - Beginning of Period 43,823,192 43,374,745 Cash and Cash Equivalents and Restricted Cash - End of Period $ 35,391,222 $ 53,501,021

Peers Headlines